Clinion Revenue and Competitors
Estimated Revenue & Valuation
- Clinion's estimated annual revenue is currently $7.3M per year.
- Clinion's estimated revenue per employee is $100,500
Employee Data
- Clinion has 73 Employees.
- Clinion grew their employee count by 35% last year.
Clinion's People
Name | Title | Email/Phone |
---|---|---|
1 | Director Pre Sales and Strategic Planning | Reveal Email/Phone |
Clinion Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 25 | N/A | N/A | N/A |
#2 | $668.1M | 3222 | 3% | $20M | N/A |
#3 | $5.3M | 46 | N/A | N/A | N/A |
#4 | $5.1M | 46 | -13% | $950K | N/A |
#5 | $1.7M | 23 | -4% | $30M | N/A |
#6 | $0.7M | 9 | N/A | N/A | N/A |
#7 | $0.7M | 9 | N/A | N/A | N/A |
#8 | $0.6M | 8 | N/A | N/A | N/A |
#9 | $71M | 300 | -3% | N/A | N/A |
#10 | $14.2M | 98 | N/A | N/A | N/A |
#11 | $5060M | 7612 | -20% | $6.9M | $22.5B |
#12 | $53.7M | 302 | 7% | $8M | N/A |
#13 | $3.8M | 33 | N/A | N/A | N/A |
#14 | $4.2M | 21 | N/A | N/A | N/A |
#15 | $7.6M | 58 | 32% | N/A | N/A |
#16 | $25.7M | 161 | N/A | N/A | N/A |
#17 | $1167M | 5806 | N/A | N/A | N/A |
#18 | $16.5M | 82 | N/A | N/A | N/A |
#19 | $12.7M | 91 | -9% | $17.2M | N/A |
#20 | N/A | 39 | N/A | N/A | N/A |
What Is Clinion?
Clinion is a life sciences technology company offering innovative software solutions in the pharmaceutical industry since 2010. Our first product, also called Clinion, is an integrated eClinical trial platform for small and medium CROs, academic research organisations and pharmaceutical companies.
keywords:Clinical trial software | Clinical data management platform | Clinical data management System | Decentralised Clinical Trial Platform | eclinical software |eClinical TechnologyN/A
Total Funding
73
Number of Employees
$7.3M
Revenue (est)
35%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 73 | 6% | N/A |
#2 | $9.5M | 73 | 28% | N/A |
#3 | N/A | 73 | 16% | N/A |
#4 | N/A | 73 | 11% | N/A |
#5 | $11M | 74 | 9% | N/A |